Cardiff Oncology Newsroom

Cardiff Oncology Is Maintained at Overweight by Piper Sandler

Dow JonesDec 13 21:24

Cardiff Oncology Analyst Ratings

BenzingaDec 13 21:14

Piper Sandler Maintains Cardiff Oncology(CRDF.US) With Buy Rating, Raises Target Price to $10

Futu NewsDec 13 20:31

TD Cowen Maintains Cardiff Oncology(CRDF.US) With Buy Rating

Futu NewsDec 13 20:31

Craig-Hallum Maintains Cardiff Oncology(CRDF.US) With Buy Rating

Futu NewsDec 10 22:31

Cardiff Oncology (CRDF) Gets a Buy From Craig-Hallum

TipRanksDec 10 21:59

Cardiff Oncology Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 9 03:40

Cardiff Oncology Analyst Ratings

BenzingaNov 9 03:31

H.C. Wainwright Maintains Cardiff Oncology(CRDF.US) With Buy Rating, Cuts Target Price to $13

Futu NewsNov 8 20:35

TD Cowen Maintains Cardiff Oncology(CRDF.US) With Buy Rating

Futu NewsNov 8 12:31

TD Cowen Reaffirms Their Buy Rating on Cardiff Oncology (CRDF)

TipRanksNov 8 12:29

Craig-Hallum Maintains Cardiff Oncology(CRDF.US) With Buy Rating, Maintains Target Price $8

Futu NewsSep 11 21:31

Cardiff Oncology Analyst Ratings

BenzingaSep 6 20:27

Craig-Hallum Initiates Cardiff Oncology(CRDF.US) With Buy Rating, Announces Target Price $8

Futu NewsSep 6 19:33

HC Wainwright & Co. : The Cardiff Oncology (CRDF.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $14.00.

Zhitong FinanceMay 6 18:31

Cardiff Oncology Analyst Ratings

BenzingaMay 6 18:31

HC Wainwright & Co. Reiterates Buy on Cardiff Oncology, Maintains $14 Price Target

BenzingaMay 6 18:30

Cardiff Oncology (CRDF) Gets a Buy From Piper Sandler

TipRanksMay 3 20:25

Cardiff Oncology Analyst Ratings

BenzingaMar 6 19:50

HC Wainwright & Co. Maintains Buy on Cardiff Oncology, Raises Price Target to $14

BenzingaMar 6 19:50